We are live on !
Find out more
&Partners Portfolio holdings
AUM
$24.4B
Turnover
11.02%
1-Year Est. Return
27.45%
This Fund
S&P 500
This Quarter Est. Return
+16.04%
1 Year Est. Return
+27.45%
3 Year Est. Return
+78.37%
5 Year Est. Return
+81.51%
10 Year Est. Return
–
AUM
$24.4B
AUM Growth
+$4.13B
(+20%)
Cap. Flow
+$1.89B
Cap. Flow % of AUM
Cap. Flow %
7.77%
Top 10 Holdings %
Top 10 Hldgs %
21.46%
Holding
2,595
New
200
Increased
1,495
Reduced
755
Closed
86
Avg Time Held
1.5
years
Top 10 Avg Time Held
2.8
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$71M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$62.1M |
| 3 |
Apple
AAPL
|
+$55.3M |
| 4 |
Microsoft
MSFT
|
+$44.6M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$41.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palo Alto Networks
PANW
|
+$14.1M |
| 2 |
First Trust Indxx Aerospace & Defense ETF
MISL
|
+$14M |
| 3 |
Procter & Gamble
PG
|
+$13.9M |
| 4 |
First Trust Energy AlphaDEX Fund
FXN
|
+$13.7M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$13.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.56% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.64% |
| 4 | Industrials | 5.77% |
| 5 | Healthcare | 5.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Vanguard Long-Term Bond ETF
BLV
$5.51B
| $19.3M | 0.08% |
280,448
+89,241
| +47% | +$6.12M |
2024 Q1
9 quarters
|
|
227
WEC Energy
WEC
$36.2B
| $19.3M | 0.08% |
165,442
+7,588
| +5% | +$866K |
2024 Q2
8 quarters
|
|
228
State Street Energy Select Sector SPDR ETF
XLE
$45.4B
| $19.3M | 0.08% |
363,667
-15,569
| -4% | -$890K |
2021 Q1
21 quarters
|
|
229
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.96B
| $19.1M | 0.08% |
77,150
-1,263
| -2% | -$272K |
2024 Q3
7 quarters
|
|
230
iShares Russell 1000 Value ETF
IWD
$84.2B
| $19M | 0.08% |
78,265
-17,264
| -18% | -$4.02M |
2023 Q4
10 quarters
|
|
231
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.7B
| $19M | 0.08% |
339,120
+28,616
| +9% | +$1.55M |
2024 Q1
9 quarters
|
|
232
Schwab US Dividend Equity ETF
SCHD
$118B
| $19M | 0.08% |
598,106
+69,869
| +13% | +$2.22M |
2023 Q4
10 quarters
|
|
233
AstraZeneca
AZN
$266B
| $19M | 0.08% |
99,983
+29,618
| +42% | +$5.57M |
2024 Q2
8 quarters
|
|
234
Trane Technologies
TT
$97.9B
| $18.9M | 0.08% |
38,393
+9,592
| +33% | +$4.49M |
2023 Q4
10 quarters
|
|
235
Marathon Petroleum
MPC
$128B
| $18.9M | 0.08% |
73,898
+4,510
| +6% | +$1.11M |
2023 Q4
10 quarters
|
|
236
Southern Company
SO
$107B
| $18.8M | 0.08% |
196,930
+12,401
| +7% | +$1.17M |
2021 Q3
19 quarters
|
|
237
Invesco NASDAQ 100 ETF
QQQM
$105B
| $18.6M | 0.08% |
61,425
+17,925
| +41% | +$5.08M |
2024 Q1
9 quarters
|
|
238
iShares US Treasury Bond ETF
GOVT
$42.4B
| $18.5M | 0.08% |
809,711
+278,002
| +52% | +$6.33M |
2024 Q3
7 quarters
|
|
239
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.58B
| $18.5M | 0.08% |
137,868
+81,245
| +143% | +$10.7M |
2024 Q3
7 quarters
|
|
240
Enterprise Products Partners
EPD
$80.1B
| $18.5M | 0.08% |
502,084
+26,347
| +6% | +$994K |
2018 Q4
30 quarters
|
|
241
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.37B
| $18.4M | 0.08% |
55,183
+51,633
| +1,454% | +$14.8M |
2024 Q4
6 quarters
|
|
242
Capital Group U.S. Small and Mid Cap ETF
CGMM
$3.47B
| $18.3M | 0.07% |
552,692
+117,368
| +27% | +$3.7M |
2025 Q1
5 quarters
|
|
243
Pfizer
PFE
$171B
| $18.2M | 0.07% |
754,925
+24,454
| +3% | +$640K |
2021 Q2
20 quarters
|
|
244
Vertiv
VRT
$74.8B
| $18.2M | 0.07% |
54,220
+10,505
| +24% | +$3.33M |
2024 Q3
7 quarters
|
|
245
Walt Disney
DIS
$194B
| $18M | 0.07% |
187,939
+9,007
| +5% | +$918K |
2018 Q4
30 quarters
|
|
246
iShares National Muni Bond ETF
MUB
$51.4B
| $18M | 0.07% |
164,088
+46,376
| +39% | +$4.96M |
2023 Q4
10 quarters
|
|
247
Schwab US Broad Market ETF
SCHB
$44.3B
| $18M | 0.07% |
619,998
+34,259
| +6% | +$959K |
2024 Q2
8 quarters
|
|
248
Invesco BulletShares 2028 Corporate Bond ETF
BSCS
$3.53B
| $17.8M | 0.07% |
873,094
+46,605
| +6% | +$951K |
2024 Q2
8 quarters
|
|
249
Arch Capital
ACGL
$34.7B
| $17.7M | 0.07% |
182,370
+10,062
| +6% | +$949K |
2024 Q2
8 quarters
|
|
250
CVS Health
CVS
$120B
| $17.6M | 0.07% |
170,584
+15,630
| +10% | +$1.4M |
2024 Q1
9 quarters
|
|
Similar funds
&Partners's Q2 2026 Portfolio in Review
As of Q2 2026, &Partners held 2,595 positions worth $24.4B, up 20% from $20.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
&Partners deployed $1.89B of net new capital in Q2 2026, opening 200 new positions and adding to 1,495 existing holdings. Its largest new stake was iShares International Country Rotation Active ETF: 434,646 shares worth $16M.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 45% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Palo Alto Networks, an estimated $14.1M trimmed.
- &Partners's largest Q2 2026 buy was iShares International Country Rotation Active ETF: 434,646 shares worth $16M.
- &Partners added most to NVIDIA in Q2 2026, an estimated $71M increase.
- &Partners's biggest Q2 2026 reduction was Palo Alto Networks, cutting an estimated $14.1M.
- &Partners fully exited Avantis Core Fixed Income ETF in Q2 2026, selling an estimated $9.19M.
- &Partners's ten largest holdings make up 21% of its $24.4B portfolio in Q2 2026.
- &Partners opened 200 new positions and closed 86 in Q2 2026.
- &Partners's portfolio value rose 20% quarter-over-quarter to $24.4B.
Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.